Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...

Viral vector manufacturing continues to face challenges in delivering consistent quality and achieving high productivity at scale. This webinar will highlight how CDMO innovation drives improvements ...

1 Bacteriology-Virology Laboratory, Fann University Hospital, Dakar, Senegal. 2 Department of Bacteriology-Virology, Faculty of Medicine, Pharmacy and Odontostomatology (FMPOS), Cheikh Anta Diop ...

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

“You have cancer.” Few words carry more weight. For people diagnosed with non–muscle invasive bladder cancer (NMIBC), advances in the field can be encouraging; yet, even amid innovation and ongoing ...

Kacey Dirksen recreates popular viral TikTok trends. Judge disqualifies top federal prosecutor in Los Angeles What's the Problem with ‘Springsteen: Deliver Me from Nowhere'? The Problem Is That ...

This is an important study that utilizes proteomic and genetic approaches to identify the glycoprotein quality control factor malectin as a pro-viral host protein involved in the replication of ...